GTS Securities’s Fresenius Medical Care FMS Stock Holding History

GTS Securities’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-206,224	Closed	-$3.98M	–	4049
2024 Q1	$3.98M	Buy	+206,224	New	+$4.09M	0.01%	1014

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return

VAG

VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return

GTS Securities's FMS Position: Q2 2024 in Review

GTS Securities sold out of Fresenius Medical Care (FMS) in Q2 2024, closing a stake of 206,224 shares — an estimated $3.98M sold.

GTS Securities first reported a position in FMS in Q1 2024 and held it in 1 quarter. The position peaked at $3.98M in Q1 2024. 167 funds tracked by Wall St. Rank hold FMS as of Q2 2024.

GTS Securities reported no remaining Fresenius Medical Care position as of Q2 2024 after selling out during the quarter.
GTS Securities sold 206,224 Fresenius Medical Care shares in Q2 2024, an estimated $3.98M.
GTS Securities first reported a position in Fresenius Medical Care in Q1 2024 and held it in 1 quarter.
GTS Securities's Fresenius Medical Care position peaked at $3.98M in Q1 2024.
167 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.